-
Kalydeco Approved in Europe to Treat Children With R117H Mutation
The European Commission has approved Kalydeco (ivacaftor) to treat children and adolescents with CF who carry the R117H mutation in the CFTR gene. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.